Latest News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.

By Xiangbin Pan, MD, PhD | Apr 28, 2025


Plant-Derived Compound Shows Early Promise for Small AAAs

In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.

By Andrew Holden, MBChB | Apr 28, 2025


Expert Perspective

Now With the TCTMD Team

Tags: CVD

Apr 04, 2025

Expert: Caitlin Cox, Yael Maxwell, Laura McKeown, Todd Neale, and Mike O'Riordan

OVERVIEW :

Hear the podcast from TCTMD covering the top stories in cardiology, latest in clinical education and an exploration...

Case Study

How to Manage TAVR Valve Embolization

Tags: TAVR

Apr 28, 2025

By: James B Hermiller MD, MSCAI

OVERVIEW :

Access the live cases featuring new techniques and therapies, Case-based presentations with interactive discussion presented during scientific meetings...

Expert Presentation

Indications and Pre-Procedural Screening for ViV/ViR Procedures

Tags: valvular heart disease

Apr 29, 2025

Expert presentations include the latest clinical data, procedural guidance, advanced expertise, late breaking clinical trials and innovative approaches...

By: Anita W Asgar MD, MSc, FSCAI

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

The novel dissolvable therapy had a 93.2% probability of being cost-effective at ...

By Andrew Holden, MBChB | Apr 25, 2025


LuX-Valve TTVR Device Provides Favorable 1-Year Results

Where this device will fit in with other emerging options remains to ...

By Andrew Holden, MBChB | Apr 25, 2025


Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Limus-based devices, rather than being a substitute for paclitaxel as they were ...

By Andrew Holden, MBChB | Apr 24, 2025


Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Ten years after learning their polygenic risk score, patients had fewer events—perhaps ...

By Andrew Holden, MBChB | Apr 24, 2025


OPINION POLL

1. Echocardiographic Strategy for ACS With COVID-19

What is your echocardiographic imaging strategy for patients who are troponin positive and COVID-19 positive?

  • No echocardiography if clinically stable
  • Point of care or focused cardiac ultrasound followed by full echocardiography if abnormalities seen
  • Standard full echocardiography when requested
  • None of the above